UNSPSC 85482021: Supplement sciatic nerve with autologous tissue substitute, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement sciatic nerve with autologous tissue substitute, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 01UF37Z

UNSPSC 85482021 Supplement sciatic nerve with autologous tissue substitute, percutaneous approach is a Commodity code that, based on recent state and local solicitations, shows no relevant procurement activity. The code nominally describes a surgical procedure, but the recent opportunities posted under this code involve occupational health surveillance, pharmacy benefit management, independent medical evaluations for pension disability determinations, surgical center-of-excellence networks, temporary health professional staffing, and emergency medical services for youth in custody — none of which align with sciatic nerve supplementation or autologous tissue procedures. The mismatch suggests either miscoding in the source data or that this Commodity code does not reflect actual state and local government buying patterns for the procedure it nominally describes.

State and local procurement offices in Arizona, California, Florida, and Washington have recently issued solicitations tagged to this code, but the work being sought — medical record summary services, pharmacy administration, occupational examinations, and temporary clinical staffing — operates in entirely different service families and would not typically require sciatic nerve surgical procedures as a component. Without recent opportunities that genuinely reflect demand for the procedure named in the code, the code presents no actionable procurement signal for vendors offering sciatic nerve supplementation services or autologous tissue grafting.